News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<H Shrs>HSI Leaps 102 Pts at Midday; CN Insurers Thrive; HENGRUI PHARMA Soars 15%
The HSI concluded the midday up 102 points or 0.4% at 25,490. The HSCEI rose 7 points or less than 0.1% to 9,157. The HSTECH fell 33 points or 0.6% to 5,644. The total market turno...
Reset
Send
The window will close in 5 seconds
<H Shrs>HSI Leaps 102 Pts at Midday; CN Insurers Thrive; HENGRUI PHARMA Soars 15%
Close
Recommend
235
Positive
403
Negative
202
 
SHORT SELL
 
STOCK INFO

The HSI concluded the midday up 102 points or 0.4% at 25,490. The HSCEI rose 7 points or less than 0.1% to 9,157. The HSTECH fell 33 points or 0.6% to 5,644. The total market turnover at midday reached HKD149.725 billion.

TENCENT (00700.HK)  -15.000 (-2.727%)    Short selling $1.95B; Ratio 16.927%   , JD-SW (09618.HK)  -0.200 (-0.163%)    Short selling $256.67M; Ratio 14.094%   , and BABA-W (09988.HK)  +1.200 (+1.037%)    Short selling $662.20M; Ratio 7.482%   have released their AI products and specifications. BABA-W rose 1.8% to HKD120.1, while TENCENT and JD-SW inched up 0.2% and 0.8%, respectively. SENSETIME-W (00020.HK)  -0.040 (-2.500%)    Short selling $70.12M; Ratio 10.542%   unveiled a new AI model, but its stock price dropped 6.9% at midday.

Among other tech stocks, BIDU-SW (09888.HK)  +0.900 (+1.064%)    Short selling $187.60M; Ratio 24.670%   edged 0.2% higher. MEITUAN-W (03690.HK)  +0.600 (+0.493%)    Short selling $1.89B; Ratio 27.601%   and KUAISHOU-W (01024.HK)  -2.400 (-3.117%)    Short selling $587.92M; Ratio 14.457%   fell less than 1%. SMIC (00981.HK)  -1.050 (-2.055%)    Short selling $241.57M; Ratio 7.234%   , NTES-S (09999.HK)  -3.000 (-1.468%)    Short selling $191.14M; Ratio 18.969%   , and BILIBILI-W (09626.HK)  -5.300 (-2.953%)    Short selling $189.58M; Ratio 16.248%   faded 1.3-1.6%. Q TECH (01478.HK)  +0.100 (+0.840%)    Short selling $8.01M; Ratio 13.838%   , NEW ORIENTAL-S (09901.HK)  -0.650 (-1.857%)    Short selling $68.06M; Ratio 22.497%   , and EAST BUY (01797.HK)  +0.900 (+4.100%)    Short selling $25.93M; Ratio 3.174%   ballooned over 3%.

In the automotive sector, XIAOMI-W (01810.HK)  +0.250 (+0.470%)    Short selling $1.00B; Ratio 14.947%   dipped 1.1%. GEELY AUTO (00175.HK)  -0.020 (-0.113%)    Short selling $165.95M; Ratio 19.328%   and LEAPMOTOR (09863.HK)  -2.250 (-3.710%)    Short selling $153.97M; Ratio 12.636%   lost 1.6% and 2.3%. BYD COMPANY (01211.HK)  +0.800 (+0.693%)    Short selling $620.96M; Ratio 13.748%   receded 0.8%.

Insurers thrived as China lowered the upper limit of the predetermined interest rate for insurance products. CHINA LIFE (02628.HK)  -0.600 (-2.637%)    Short selling $740.74M; Ratio 24.832%   , CPIC (02601.HK)  -0.900 (-2.844%)    Short selling $60.78M; Ratio 6.859%   , PING AN (02318.HK)  -1.050 (-1.946%)    Short selling $928.57M; Ratio 22.144%   , and CHINA TAIPING (00966.HK)  -0.400 (-2.286%)    Short selling $13.01M; Ratio 6.726%   advanced 2.7-3.5%. AIA (01299.HK)  -2.050 (-2.793%)    Short selling $188.92M; Ratio 11.241%   was even hyped up 4.5%.

HENGRUI PHARMA (01276.HK)  -3.750 (-4.756%)   announced an innovative drug licensing agreement with GSK, under which HENGRUI PHARMA will receive an upfront payment of USD500 million. If all projects are successfully developed and achieve commercial milestones, the potential total amount could reach around USD12 billion. HENGRUI PHARMA's stock price rocketed 15.4% at midday.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-08-01 16:25.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.